Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

NCT04221438 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

NETWORK

Sponsor class

Stopped Slow accrual

Conditions

Melanoma of Unknown Primary
Metastatic Malignant Neoplasm in Lymph Node
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Recurrent Cutaneous Melanoma

Interventions

DRUG: Binimetinib
PROCEDURE: Conventional Surgery
DRUG: Encorafenib
OTHER: Fluorothymidine F-18

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]